EUVIMEDOdkrijte EUVIMED
Open access · CC BY-NC 4.0

PpIX ‐enabled fluorescence‐based detection and photodynamic priming of platinum‐resistant ovarian cancer cells under fluid shear stress

Mustafa Kemal Ruhi, Brittany P Rickard iD, Marta Overchuk iD, Prima Dewi Sinawang iD, Elizabeth Stanley, Matthew Mansi, Raymond G Sierra, Brandon Hayes, Xianming Tan, Demir Akin, Bin Chen iD, Utkan Demirci and 1 more

Photochemistry and Photobiology · 2024

DOI: 10.1111/php.14014 ↗

At a glance

Journal article in Photochemistry and Photobiology, 2024. Written by Mustafa Kemal Ruhi and 12 co-authors. Institution: Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carol…. Major MEDLINE topics: Ovarian Neoplasms, Drug Resistance, Neoplasm, Protoporphyrins, Photochemotherapy. Cited 8 times so far (Crossref); 88 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NCATS NIH HHS, NCI NIH HHS, NIEHS NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Over 75% percent of ovarian cancer patients are diagnosed with advanced‐stage disease characterized by unresectable intraperitoneal dissemination and the presence of ascites, or excessive fluid build‐up within the abdomen. Conventional treatments include cytoreductive surgery followed by multi‐line platinum and taxane chemotherapy regimens. Despite an initial response to treatment, over 75% of patients with advanced‐stage ovarian cancer will relapse and succumb to platinum‐resistant disease. Recent evidence suggests that fluid shear stress (FSS), which results from the movement of fluid such as ascites, induces epithelial‐to‐mesenchymal transition and confers resistance to carboplatin in ovarian cancer cells. This study demonstrates, for the first time, that FSS‐induced platinum resistance correlates with increased cellular protoporphyrin IX (PpIX), the penultimate downstream product of heme biosynthesis, the production of which can be enhanced using the clinically approved pro‐drug aminolevulinic acid (ALA). These data suggest that, with further investigation, PpIX could serve as a fluorescence‐based biomarker of FSS‐induced platinum resistance. Additionally, this study investigates the efficacy of PpIX‐enabled photodynamic therapy (PDT) and the secretion of extracellular vesicles under static and FSS conditions in Caov‐3 and NIH:OVCAR‐3 cells, two representative cell lines for high‐grade serous ovarian carcinoma (HGSOC), the most lethal form of the disease. FSS induces resistance to ALA‐PpIX‐mediated PDT, along with a significant increase in the number of EVs. Finally, the ability of PpIX‐mediated photodynamic priming (PDP) to enhance carboplatin efficacy under FSS conditions is quantified. These preliminary findings in monolayer cultures necessitate additional studies to determine the feasibility of PpIX as a fluorescence‐based indicator, and mediator of PDP, to target chemoresistance in the context of FSS.

Subjects

MeSH terms (MEDLINE)

Ovarian NeoplasmsDrug Resistance, NeoplasmProtoporphyrinsPhotochemotherapyHumansFemaleCell Line, TumorAminolevulinic AcidPhotosensitizing AgentsCarboplatinPlatinumFluorescenceStress, MechanicalAntineoplastic Agents

Author keywords

fluid shear stressovarian cancerphotodynamic primingplatinum resistanceprotoporphyrin IX

Substances

protoporphyrin IXProtoporphyrinsAminolevulinic AcidPhotosensitizing AgentsCarboplatinPlatinumAntineoplastic Agents

Authors and institutions

  • Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina, USA.
  • Institute of Biomedical Engineering, Boğaziçi University, Istanbul, Turkey.
  • Curriculum in Toxicology & Environmental Medicine, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Chemical Engineering, School of Engineering, Stanford University, Stanford, California, USA.
  • Bio-Acoustic MEMS in Medicine (BAMM) Laboratories, Department of Radiology, School of Medicine, Stanford University, Palo Alto, California, USA.
  • Department of Radiology, School of Medicine, Canary Center at Stanford, Stanford University, Palo Alto, California, USA.

ORCID profiles: Brittany P Rickard, Marta Overchuk, Prima Dewi Sinawang, Bin Chen, Imran Rizvi

Funding

  • NCATS NIH HHS
  • NCI NIH HHS
  • NIEHS NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institute of Environmental Health Sciences
  • National Cancer Institute

Cite

APA

Ruhi, M. K., Rickard, B. P., Overchuk, M., Sinawang, P. D., Stanley, E., Mansi, M., Sierra, R. G., Hayes, B., Tan, X., Akin, D., Chen, B., Demirci, U., & Rizvi, I. (2024). PpIX ‐enabled fluorescence‐based detection and photodynamic priming of platinum‐resistant ovarian cancer cells under fluid shear stress. Photochemistry and Photobiology. https://doi.org/10.1111/php.14014

Vancouver

Ruhi MK, Rickard BP, Overchuk M, Sinawang PD, Stanley E, Mansi M, et al. PpIX ‐enabled fluorescence‐based detection and photodynamic priming of platinum‐resistant ovarian cancer cells under fluid shear stress. Photochemistry and Photobiology. 2024. doi:10.1111/php.14014

BibTeX
@article{Ruhi2024,
  author = {Ruhi, Mustafa Kemal and Rickard, Brittany P and Overchuk, Marta and Sinawang, Prima Dewi and Stanley, Elizabeth and Mansi, Matthew and Sierra, Raymond G and Hayes, Brandon and Tan, Xianming and Akin, Demir and Chen, Bin and Demirci, Utkan and Rizvi, Imran},
  title = {PpIX ‐enabled fluorescence‐based detection and photodynamic priming of platinum‐resistant ovarian cancer cells under fluid shear stress},
  journal = {Photochemistry and Photobiology},
  year = {2024},
  doi = {10.1111/php.14014}
}
Start for free →